
Novel ингибитор of glutaminase 1 (GLS1) with high связывание affinity (SPR, Kd = 24 nM; ITC, Kd = 37 nM), exhibiting a similar in vivo antitumor activity as CB839
Novel inhibitor of glutaminase 1 (GLS1) with high binding affinity (SPR, Kd = 24 nM; ITC, Kd = 37 nM), exhibiting a similar in vivo antitumor activity as CB839
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.